Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic phase of chronic myeloid leukemia [7]

Blood

Volumn 94, Issue 11, 1999, Pages 3960-3962

  Clift, R A ^a   Radich, J ^a   Appelbaum, F R ^a   Martin, P ^a   Flowers, M E D ^a   Deeg, H J ^a   Storb, R ^a   Thomas, E D ^a  

^a Seattle Marrow Transplant Team   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; INTERFERON;

ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 0033485937     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.11.3960a.423a43g_3960_3962     Document Type: Letter

References (4)